title: Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.
abstract: Recent advances in therapeutic tumor vaccinations necessitate the identification of broadly expressed, immunogenic tumor antigens that are not prone to immune selection. To this end, the human inhibitor of apoptosis, survivin, is a prime candidate because it is expressed in most human neoplasms but not in normal, differentiated tissues. Here, we demonstrate spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in breast cancer, leukemia, and melanoma patients both in situ as well as ex vivo. Moreover, survivin-reactive T cells isolated by magnetic beads coated with MHC/peptide complexes were cytotoxic against HLA-matched tumors of different tissue types. Being a universal tumor antigen, survivin may serve as a widely applicable target for anticancer immunotherapy.
authors.affiliation: Department of Tumor Cell Biology, Danish Cancer Society, 2100 Copenhagen, Denmark. mha@cancer.dk
authors.forename: M H
authors.initials: MH
authors.lastname: Andersen
authors.forename: L O
authors.initials: LO
authors.lastname: Pedersen
authors.forename: B
authors.initials: B
authors.lastname: Capeller
authors.forename: E B
authors.initials: EB
authors.lastname: Bröcker
authors.forename: J C
authors.initials: JC
authors.lastname: Becker
authors.forename: P
authors.initials: P
authors.lastname: thor Straten
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology* / Q000494:pharmacology; D001943:Breast Neoplasms / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D015789:HLA-A2 Antigen / Q000276:immunology*; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology*; D008545:Melanoma / Q000276:immunology*; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D010446:Peptide Fragments / Q000276:immunology / Q000494:pharmacology; D011506:Proteins / Q000276:immunology* / Q000494:pharmacology; D000077022:Survivin; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured
chemical_list: D000951:Antigens, Neoplasm; C107489:BIRC5 protein, human; D018984:Epitopes, T-Lymphocyte; D015789:HLA-A2 Antigen; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D010446:Peptide Fragments; D011506:Proteins; D000077022:Survivin